| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 30654 |
| 1 | METHOTREXATE SODIUM | 28352 |
| 2 | PREDNISONE | 28098 |
| 3 | ERGOCALCIFEROL | 27578 |
| 4 | ADALIMUMAB | 27276 |
| 5 | ASPIRIN | 27010 |
| 6 | OMEPRAZOLE MAGNESIUM | 26440 |
| 7 | ASPIRIN 81 MG | 25890 |
| 8 | ASPIRIN 325 MG | 25879 |
| 9 | METHOTREXATE | 24210 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRISODIUM CITRATE DIHYDRATE | 3049 | 0.4447 |
| 1 | ZOLBETUXIMAB | 428 | 0.3970 |
| 2 | SELINEXOR | 2559 | 0.3061 |
| 3 | ESTRIOL | 488 | 0.2919 |
| 4 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 423 | 0.2684 |
| 5 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 1145 | 0.2640 |
| 6 | NIRAPARIB | 5771 | 0.2632 |
| 7 | RUCAPARIB | 2258 | 0.2578 |
| 8 | CAFFEINE CITRATE | 556 | 0.2548 |
| 9 | NICOTINAMIDE | 594 | 0.2470 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 73195 |
| 1 | Corticosteroid [EPC] | 60540 |
| 2 | GLP-1 Receptor Agonist [EPC] | 53964 |
| 3 | Benzodiazepine [EPC] | 42402 |
| 4 | Proton Pump Inhibitor [EPC] | 34074 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 33073 |
| 6 | Kinase Inhibitor [EPC] | 30673 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 28533 |
| 8 | Vitamin C [EPC] | 27790 |
| 9 | Provitamin D2 Compound [EPC] | 27576 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | APOC-III-directed RNA Interaction [EPC] | 7 | 0.4375 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 428 | 0.3970 |
| 2 | Nuclear Export Inhibitor [EPC] | 2559 | 0.3061 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 180 | 0.2927 |
| 4 | Melanocortin 4 Receptor Agonist [EPC] | 72 | 0.2738 |
| 5 | Gamma Secretase Inhibitor [EPC] | 184 | 0.2332 |
| 6 | CD3-directed Antibody [EPC] | 107 | 0.2170 |
| 7 | Cholinergic Muscarinic Agonist [EPC] | 358 | 0.2059 |
| 8 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 876 | 0.1830 |